Company Filing History:
1 out of 1 
1 out of 832,912 Years Active: 2001-2002
Title: The Innovations of Stan Bastiras
Introduction
Stan Bastiras is an accomplished inventor based in Adelaide, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents targeting specific biological pathways. With a total of 2 patents to his name, Bastiras has demonstrated a commitment to advancing medical science through innovative solutions.
Latest Patents
One of his latest patents is focused on an Interleukin-5 antagonist. This invention relates to modified and variant forms of Interleukin-5 molecules that are capable of antagonizing or reducing the activity of IL-5. The application of this invention aims to ameliorate, abate, or otherwise reduce the aberrant effects caused by native or mutant forms of IL-5. Another notable patent is for haemopoietic growth factor antagonists and their uses. This invention encompasses variant recombinant forms of haemopoietic growth factors that serve as antagonists to the corresponding native haemopoietic growth factor. The goal is to ameliorate aberrant effects caused by the native molecules and to aid in the treatment of tumors, cancers, and inflammation.
Career Highlights
Throughout his career, Stan Bastiras has worked with various organizations, including Breasagen Limited. His work has been instrumental in pushing the boundaries of what is possible in the realm of medical treatments and therapies.
Collaborations
Bastiras has collaborated with notable professionals in his field, including Angel Francisco Lopez and Mathew A Vadas. These collaborations have likely contributed to the success and development of his innovative patents.
Conclusion
Stan Bastiras is a prominent figure in the field of biotechnology, with a focus on developing innovative solutions for medical challenges. His patents reflect a deep understanding of biological mechanisms and a commitment to improving health outcomes.